跳至主要内容
临床试验/NCT02703090
NCT02703090已完成不适用

Assessing the Cortical Response to Noxious and Auditory Stimuli Using Near Infrared Spectroscopy in Subjects Under General Anesthesia

Boston Children's Hospital1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2016年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
44
试验地点
1
主要终点
Changes in Cortical Oxyhemoglobin Concentrations to Ablation

研究概览

简要总结

The primary aim is to utilize near-infrared spectroscopy (NIRS) in patients under general anesthesia to measure changes in brain blood flow in the bilateral somatosensory cortices and the prefrontal cortices in response to noxious stimulation.

详细描述

Participants:

Patients with a structurally normal heart scheduled to undergo elective electrophysiology study with catheter ablation of an arrhythmia under general anesthesia were recruited. Forty one patients were enrolled from October 2016 to March 2020. Written informed consent was obtained from the participants or their respective parents/guardians before the study and written assent was obtained from children ≥7 years of age. All study procedures were approved by the Institutional Review Board (IRB-P00021030) of Boston Children's Hospital, Boston, Massachusetts and the study registered with clinicaltrials.gov (NCT02703090).

Randomization, Allocation concealment and blinding:

The hospital research pharmacy used a parallel group design, with block randomization to allocate the patients into either high-dose, low-dose or placebo groups. The clinical staff, research personnel and the patients were unaware of the drug allocated to a particular patient (double-blinded). The decision to unblind was made by the principal investigators (B.K and D.B) and performed by the pharmacy after all the data were acquired, preprocessed and were ready for group level statistical analysis.

Power Analysis:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
12 Years 至 30 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • 12-30 years of age
  • Structurally normal heart
  • Right-handed
  • English-speaking

排除标准

  • Unable to cooperate or understand the study
  • Neurologic disease
  • Diabetes mellitus
  • Syndrome of greater than minor severity.
  • Scalp or hair does not permit sufficient optical light detection
  • Unable to keep his/her head still for a period of 200 consecutive seconds

研究组 & 干预措施

Placebo

Placebo Comparator

Normal saline infusion

干预措施: Normal saline (Drug)

Drug lower dose

Active Comparator

Remifentanil infusion

干预措施: Remifentanil (Drug)

Drug higher dose

Active Comparator

Remifentanil infusion

干预措施: Remifentanil (Drug)

结局指标

主要结局

Changes in Cortical Oxyhemoglobin Concentrations to Ablation

时间窗: during the 0- to 15-second period following the start of stimulus

Changes in oxyhemoglobin concentration area under the curve (AUC) to ablation in placebo vs. remifentanil groups.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Barry Kussman

Senior Associate in Cardiac Anesthesia

Boston Children's Hospital

研究点 (1)

Loading locations...

相似试验